Balancing the risks and benefits of biologic drugs in rheumatic disease: the case for romosozumab?
Main Author: | |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2020-01-01
|
Series: | Therapeutic Advances in Musculoskeletal Disease |
Online Access: | https://doi.org/10.1177/1759720X19895490 |
id |
doaj-4711a834c1574ee1b84a922a7f2e9669 |
---|---|
record_format |
Article |
spelling |
doaj-4711a834c1574ee1b84a922a7f2e96692021-07-14T11:33:36ZengSAGE PublishingTherapeutic Advances in Musculoskeletal Disease1759-72182020-01-011210.1177/1759720X19895490Balancing the risks and benefits of biologic drugs in rheumatic disease: the case for romosozumab?David M. Reidhttps://doi.org/10.1177/1759720X19895490 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
David M. Reid |
spellingShingle |
David M. Reid Balancing the risks and benefits of biologic drugs in rheumatic disease: the case for romosozumab? Therapeutic Advances in Musculoskeletal Disease |
author_facet |
David M. Reid |
author_sort |
David M. Reid |
title |
Balancing the risks and benefits of biologic drugs in rheumatic disease: the case for romosozumab? |
title_short |
Balancing the risks and benefits of biologic drugs in rheumatic disease: the case for romosozumab? |
title_full |
Balancing the risks and benefits of biologic drugs in rheumatic disease: the case for romosozumab? |
title_fullStr |
Balancing the risks and benefits of biologic drugs in rheumatic disease: the case for romosozumab? |
title_full_unstemmed |
Balancing the risks and benefits of biologic drugs in rheumatic disease: the case for romosozumab? |
title_sort |
balancing the risks and benefits of biologic drugs in rheumatic disease: the case for romosozumab? |
publisher |
SAGE Publishing |
series |
Therapeutic Advances in Musculoskeletal Disease |
issn |
1759-7218 |
publishDate |
2020-01-01 |
url |
https://doi.org/10.1177/1759720X19895490 |
work_keys_str_mv |
AT davidmreid balancingtherisksandbenefitsofbiologicdrugsinrheumaticdiseasethecaseforromosozumab |
_version_ |
1721303008061423616 |